Mercy Medical Center is now offering screening colonoscopy patients a new technology to aid in the detection of colorectal polyps – the GI GeniusTM intelligent endoscopy module. The GI GeniusTM module uses artificial intelligence (AI) to assist physicians as they screen for colorectal cancer. Mercy is the first hospital in Iowa to acquire this technology.
The GI GeniusTM module uses advanced AI software to highlight suspicious polyps with a visual marker in real time, thereby assisting the gastroenterologist in the detection of lesions. Studies have shown that AI-assisted colonoscopy can increase polyp detection rates.
Colorectal cancer is the third-most common form of cancer diagnosed in the U.S., with almost 150,000 new cases every year. Colonoscopy has long been considered the gold standard for detecting polyps that can eventually lead to colorectal cancer. Now, patients have the added benefit of this AI technology to help physicians detect polyps.
“Mercy remains focused on meeting the medical needs of our community by providing our staff with the latest technology and tools for ongoing, high-quality care,” said Dr. Bhavya Akhauri, medical director, Mercy Gastroenterology Clinic. “The GI GeniusTM module is the first and only AI system for aiding detection of colonic polyps in the U.S. and we are pleased to be at the forefront in Iowa in offering it to our patients.”
The Mercy Gastroenterology Clinic provides its patients with a high standard of care, as reflected in its quality data. It’s also been recognized by the American Society for Gastrointestinal Endoscopy for meeting the program’s rigorous criteria in areas such as quality assurance, CDC infection control guidelines and endoscopy staff competency.
The American Cancer Society recommends that adults begin colorectal cancer screening at the age of 45. Colorectal cancer usually starts from polyps or precancerous growths in the colon and rectum.
